The South Africa anti-infective market is expected to reach US$ 2,572.5 Mn in 2027 from US$ 1,893.5 Mn in 2018. The market is estimated to grow with a CAGR of 3.6% from 2019-2027.
The growth of the market is driven by the factors such as,rise in the cases of viral diseases in South Africa. However, the market is likely to get impacted due to lack of awareness regarding fungal infections in South Africa.
In South Africa, almost 7.52 million people were living with HIV in 2018, as per data released by GHE. Also, during the year 2017, approximately 21% of South Africa patients living with HIV were from South Africa. The projected overall HIV prevalence rate during 2018 was almost 13.1% among the South African population, whereas for adults between 15-49 years, an estimated 19.0% of the population is found to be HIV positive. Also, South Africa has one of the highest rates of liver cancer in the world, which is related to the increased rate of HBV among adults.
Also, the incidences of tinea capitis are dominating in South Africa. Also, the country has a more significant number of tuberculosis and HIV, which further leads to a considerable amount of cases for chronic pulmonary aspergillosis (CPA). Moreover, as the data published at Gulf Conference on Clinical Microbiology and Infectious Diseases stated that approximately 99,350 cases of CPA were present in South Africa. The prevalence rate was nearly 175/100,000, which is the highest prevalence in the world. Furthermore, as per the data published by the CDC in April 2019 stated that in 2012-2016, Candida auris affected nearly 451 patients across the country. Therefore, owing to increasing prevalence across the country are likely to drive the growth of the anti-infective market during the forecast period.
South Africa anti-infective market, based on distribution channel was segmented into hospital pharmacies, retail pharmacies, and online pharmacies. In 2018, the hospital pharmacies segment held the largest share of the market, by distribution channel. This segment is also anticipated to grow at the highest rate during the forecast period.
Exhibit: South Africa Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
ASIA PACIFIC DIABETES CARE DEVICES – MARKET SEGMENTATION
By Type
By Application
By Distribution Channel
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 1,893.5 Million |
| Market Size by 2027 | US$ 2,572.5 Million |
| CAGR (2019 - 2027) | 3.6% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By Type
|
|
Regions and Countries Covered
|
|
| South Africa | |
| Market leaders and key company profiles |
|
The South Africa Anti-Infective Market is valued at US$ 1,893.5 Million in 2018, it is projected to reach US$ 2,572.5 Million by 2027.
As per our report South Africa Anti-Infective Market, the market size is valued at US$ 1,893.5 Million in 2018, projecting it to reach US$ 2,572.5 Million by 2027. This translates to a CAGR of approximately 3.6% during the forecast period.
The South Africa Anti-Infective Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South Africa Anti-Infective Market report:
The South Africa Anti-Infective Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South Africa Anti-Infective Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South Africa Anti-Infective Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+1 646 791 7070
sales@businessmarketinsights.com
Get Free Sample For South Africa Anti-Infective Market
